For a patient with COPD on long-term oxygen therapy, what SpO2 target range is typically recommended to minimize CO2 retention?

Prepare for the NCLEX Oxygenation Test with flashcards and multiple choice questions. Each question comes with detailed explanations and hints. Ace your exam!

Multiple Choice

For a patient with COPD on long-term oxygen therapy, what SpO2 target range is typically recommended to minimize CO2 retention?

Explanation:
In COPD with chronic CO2 retention, oxygen must be titrated carefully to avoid suppressing the drive to breathe while still providing adequate oxygenation. Giving too much oxygen can blunt the hypoxic ventilatory drive and worsen CO2 retention, and it can also worsen ventilation–perfusion mismatch, raising arterial CO2. Therefore, the usual SpO2 target on long-term oxygen therapy for these patients is 88–92%. This range helps ensure sufficient oxygenation without pushing CO2 levels higher. Higher targets, such as 94–98% or 95–100%, increase the risk of hypercapnia in COPD patients who rely on low oxygen levels to drive breathing. If SpO2 trends above 92%, oxygen therapy can be adjusted downward with appropriate monitoring (often via ABG) to maintain the safer range.

In COPD with chronic CO2 retention, oxygen must be titrated carefully to avoid suppressing the drive to breathe while still providing adequate oxygenation. Giving too much oxygen can blunt the hypoxic ventilatory drive and worsen CO2 retention, and it can also worsen ventilation–perfusion mismatch, raising arterial CO2. Therefore, the usual SpO2 target on long-term oxygen therapy for these patients is 88–92%. This range helps ensure sufficient oxygenation without pushing CO2 levels higher. Higher targets, such as 94–98% or 95–100%, increase the risk of hypercapnia in COPD patients who rely on low oxygen levels to drive breathing. If SpO2 trends above 92%, oxygen therapy can be adjusted downward with appropriate monitoring (often via ABG) to maintain the safer range.

More practice questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy